Ertapenem

What is Ertapenem?

Ertapenem is a potent, broad-spectrum carbapenem antibiotic belonging to the beta-lactam class of antibacterial drugs. It is primarily used to treat moderate to severe bacterial infections caused by susceptible microorganisms. Designed for once-daily dosing, Ertapenem is effective against a range of Gram-positive, Gram-negative, and anaerobic bacteria, but generally not against non-fermenting Gram-negative bacteria like Pseudomonas aeruginosa or Acinetobacter species. Its unique pharmacokinetic profile allows for convenient administration, making it a valuable option in both hospital and outpatient settings for specific types of infections.

How Does it Work?

The mechanism of action of Ertapenem, like other beta-lactam antibiotics, involves inhibiting bacterial cell wall synthesis. It achieves this by binding to penicillin-binding proteins (PBPs) located on the bacterial cell membrane. PBPs are crucial enzymes involved in the final stages of peptidoglycan synthesis, essential for maintaining the structural integrity of the bacterial cell wall. By disrupting this process, Ertapenem leads to the formation of defective cell walls, causing bacterial cell lysis and death. This bactericidal action makes it highly effective against a wide array of susceptible bacteria. Its stability against hydrolysis by many beta-lactamases, including extended-spectrum beta-lactamases (ESBLs), further enhances its efficacy against resistant strains.

Medical Uses

Ertapenem is approved for the treatment of various serious bacterial infections. Its broad-spectrum antibiotic activity makes it suitable for empirical therapy in specific clinical scenarios. Key medical uses include:

• Complicated Intra-abdominal Infections (cIAI): Often used in conjunction with metronidazole for optimal coverage.
• Complicated Skin and Skin Structure Infections (cSSSI): Including diabetic foot infections without osteomyelitis.
• Community-Acquired Pneumonia (CAP): Particularly when caused by multi-drug resistant pathogens.
• Complicated Urinary Tract Infections (cUTI): Including pyelonephritis.
• Acute Pelvic Infections: Including postpartum endomyometritis and post-surgical gynecological infections.
• Prophylaxis in Colorectal Surgery: Used for surgical prophylaxis to prevent post-operative infections.

It is important to note that Ertapenem is not recommended for infections caused by Pseudomonas aeruginosa or Acinetobacter species. Prescribing decisions should always be based on susceptibility testing and clinical guidelines.

Dosage

The standard adult dosage for Ertapenem is typically 1 gram (1000 mg) administered once daily. It can be given either by intravenous administration (IV) as an infusion over 30 minutes or intramuscularly (IM). The duration of treatment depends on the type and severity of the infection, usually ranging from 3 to 14 days. For complicated intra-abdominal infections, it may be used for up to 5-14 days. In cases of renal impairment, dosage adjustments are necessary. For patients with creatinine clearance (CrCl) between 30-39 mL/min, the dose is reduced to 500 mg once daily. For CrCl less than 30 mL/min, including those on hemodialysis, the dose is also 500 mg once daily, administered after hemodialysis on dialysis days. Intramuscular administration should only be used when IV is not feasible and is prepared with lidocaine to minimize pain.

Side Effects

Like all medications, Ertapenem can cause side effects. Common side effects are generally mild to moderate and may include:

• Nausea, diarrhea, constipation
• Headache, dizziness
• Injection site reactions (pain, redness, swelling)
• Rash, vaginitis

More serious, though less common, side effects warrant immediate medical attention:

• Allergic reactions: Severe rash, itching, swelling, severe dizziness, trouble breathing.
• Seizures: More common in patients with pre-existing central nervous system disorders or renal impairment.
• Clostridioides difficile-associated diarrhea (CDAD): Can range from mild diarrhea to life-threatening colitis.
• Liver problems: Rarely, elevated liver enzymes.

Patients should inform their doctor about any unusual or persistent side effects.

Drug Interactions

Several drug interactions with Ertapenem are important to consider:

• Valproic Acid/Divalproex Sodium: Co-administration with carbapenems, including Ertapenem, can significantly decrease valproic acid plasma concentrations, potentially leading to a loss of seizure control. Alternative anticonvulsant therapy should be considered.
• Probenecid: This medication inhibits the renal excretion of Ertapenem, leading to increased and prolonged plasma concentrations.
• Oral Contraceptives: Some antibiotics can reduce the effectiveness of oral contraceptives. Patients should be advised to use an alternative or additional method of contraception.
• Anticoagulants (e.g., Warfarin): Antibiotics can sometimes alter gut flora, potentially affecting vitamin K production and enhancing the effect of warfarin. Close monitoring of INR is advisable.

Always inform your healthcare provider about all medications you are taking.

FAQ

Is Ertapenem a broad-spectrum antibiotic?

Yes, Ertapenem is considered a broad-spectrum antibiotic, effective against a wide range of Gram-positive, Gram-negative, and anaerobic bacteria. However, it typically does not cover non-fermenting Gram-negative bacteria like Pseudomonas aeruginosa.

How quickly does Ertapenem start working?

Ertapenem begins to work relatively quickly after administration, with therapeutic concentrations achieved rapidly. Clinical improvement is usually observed within a few days, depending on the severity and type of infection.

Can Ertapenem be taken orally?

No, Ertapenem is not available in an oral form. It must be administered intravenously (IV) or intramuscularly (IM) as it is not well absorbed from the gastrointestinal tract.

Products containing Ertapenem are available through trusted online pharmacies. You can browse Ertapenem-based medications at ShipperVIP or Medicenter.

Summary

Ertapenem is a crucial carbapenem antibiotic for treating a variety of serious bacterial infections. Its once-daily dosing regimen and broad-spectrum activity against many common pathogens make it a convenient and effective treatment option. While generally well-tolerated, awareness of its potential side effects and drug interactions is essential for safe and effective use. Appropriate prescribing based on susceptibility and clinical need is paramount to combat antibiotic resistance and ensure optimal patient outcomes.